Fate Therapeutics (FATE) Payables (2016 - 2025)
Historic Payables for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $3.5 million.
- Fate Therapeutics' Payables fell 4481.02% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 4481.02%. This contributed to the annual value of $9.4 million for FY2024, which is 9845.31% up from last year.
- Per Fate Therapeutics' latest filing, its Payables stood at $3.5 million for Q3 2025, which was down 4481.02% from $4.0 million recorded in Q2 2025.
- Fate Therapeutics' 5-year Payables high stood at $11.4 million for Q1 2022, and its period low was $3.5 million during Q3 2025.
- Over the past 5 years, Fate Therapeutics' median Payables value was $6.8 million (recorded in 2024), while the average stood at $7.1 million.
- As far as peak fluctuations go, Fate Therapeutics' Payables plummeted by 5745.04% in 2021, and later soared by 9845.31% in 2024.
- Quarter analysis of 5 years shows Fate Therapeutics' Payables stood at $8.6 million in 2021, then decreased by 4.03% to $8.3 million in 2022, then tumbled by 42.9% to $4.7 million in 2023, then skyrocketed by 98.45% to $9.4 million in 2024, then plummeted by 62.58% to $3.5 million in 2025.
- Its Payables was $3.5 million in Q3 2025, compared to $4.0 million in Q2 2025 and $4.2 million in Q1 2025.